3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Hodgkin Disease
3
Breast Neoplasms
3
Lymphoma, Non-Hodgkin
2
Leukemia
2
Triple Negative Breast Neoplasms
1
Teratoma
1
Rhabdomyosarcoma
1
Renal Pelvis and Ureter Urothelial Carcinoma
1
Recurrence
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Neoplasms
1
Pain
1
Lymphoma, T-Cell
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, AIDS-Related
1
Lymphoma
1
Inflammatory Breast Neoplasms
1
Infiltrating Bladder Urothelial Carcinoma
1
Glioma
1
Choriocarcinoma
1
Central Nervous System Neoplasms
1
Carcinoma, Embryonal
1
Burkitt Lymphoma
1
Adenocarcinoma, Bronchiolo-Alveolar
1
Adenocarcinoma of Lung
1
Interventions
Specimen Handling
3
Magnetic Resonance Spectroscopy
3
olaparib
2
lutetium Lu 177 dotatate
2
gallium Ga 68 dotatate
2
Fluorodeoxyglucose F18
2
6-fluorodopamine
2
tipifarnib
1
fluorodopa F 18
1
fludarabine phosphate
1
belzutifan
1
Temozolomide
1
Nivolumab
1
Ipilimumab
1
Interleukin-13
1
Cyclophosphamide
1
Contrast Media
1
CTLA-4 Antigen
1
Biopsy
1
3-Iodobenzylguanidine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Pheochromocytoma
×
pegfilgrastim
×
90 days
×
Clear all
No trials found.